408 related articles for article (PubMed ID: 6319219)
1. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease.
Sharon P; Stenson WF
Gastroenterology; 1984 Mar; 86(3):453-60. PubMed ID: 6319219
[TBL] [Abstract][Full Text] [Related]
2. Alteration of prostaglandin E2 and leukotriene B4 synthesis in chronic inflammatory bowel disease.
Schmidt C; Baumeister B; Kipnowski J; Schiermeyer-Dunkhase B; Vetter H
Hepatogastroenterology; 1996; 43(12):1508-12. PubMed ID: 8975956
[TBL] [Abstract][Full Text] [Related]
3. [Leukotriene synthesis by gastrointestinal tissue and its pharmacologic modification].
Peskar BM; Kozuschek W; Morgenroth K; Hoppe U; Dreyling KW; Peskar BA
Wien Klin Wochenschr; 1986 Feb; 98(4):98-104. PubMed ID: 3010577
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of arachidonic acid in acetic acid colitis in rats. Similarity to human inflammatory bowel disease.
Sharon P; Stenson WF
Gastroenterology; 1985 Jan; 88(1 Pt 1):55-63. PubMed ID: 3917261
[TBL] [Abstract][Full Text] [Related]
5. Altered leukotriene B4 metabolism in colonic mucosa with inflammatory bowel disease.
Ikehata A; Hiwatashi N; Kinouchi Y; Yamazaki H; Ito K; Toyota T
Scand J Gastroenterol; 1995 Jan; 30(1):44-9. PubMed ID: 7701249
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-8 and neutrophil markers in colonic mucosa from patients with ulcerative colitis.
Izzo RS; Witkon K; Chen AI; Hadjiyane C; Weinstein MI; Pellecchia C
Am J Gastroenterol; 1992 Oct; 87(10):1447-52. PubMed ID: 1329495
[TBL] [Abstract][Full Text] [Related]
7. Arachidonic acid metabolism and intracellular calcium concentration in inflammatory bowel disease.
Schmidt C; Kosché E; Baumeister B; Vetter H
Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):865-9. PubMed ID: 8574719
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
9. Chemotactic activity in inflammatory bowel disease. Role of leukotriene B4.
Lobos EA; Sharon P; Stenson WF
Dig Dis Sci; 1987 Dec; 32(12):1380-8. PubMed ID: 2826090
[TBL] [Abstract][Full Text] [Related]
10. Electrolyte transport across colonic mucosa from patients with inflammatory bowel disease.
Hawker PC; McKay JS; Turnberg LA
Gastroenterology; 1980 Sep; 79(3):508-11. PubMed ID: 7429111
[TBL] [Abstract][Full Text] [Related]
11. Effect of aspirin on prostaglandin E2 and leukotriene B4 production in human colonic mucosa from cancer patients.
Frommel TO; Dyavanapalli M; Oldham T; Kazi N; Lietz H; Liao Y; Mobarhan S
Clin Cancer Res; 1997 Feb; 3(2):209-13. PubMed ID: 9815674
[TBL] [Abstract][Full Text] [Related]
12. 15-HETE is the main eicosanoid formed by human colonic mucosa.
Zijlstra FJ; van Dijk AP; Wilson JH; van Riemsdijk-Overbeeke IC; Vincent JE; Ouwendijk RJ
Agents Actions; 1992; Spec No():C53-9. PubMed ID: 1442336
[TBL] [Abstract][Full Text] [Related]
13. [Synthesis of eicosanoids in the colonic mucosa in patients with ulcerative colitis].
Pavlenko VV; Iagoda AV
Klin Med (Mosk); 2003; 81(10):39-43. PubMed ID: 14664173
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
[TBL] [Abstract][Full Text] [Related]
15. Drug treatment and formation of eicosanoids in patients with chronic inflammatory bowel disease.
Lauritsen K
Dan Med Bull; 1989 Sep; 36(4):378-93. PubMed ID: 2572403
[No Abstract] [Full Text] [Related]
16. Effect of the leukotriene B4 receptor antagonist SC-41930 on colonic inflammation in rat, guinea pig and rabbit.
Fretland DJ; Widomski D; Tsai BS; Zemaitis JM; Levin S; Djuric SW; Shone RL; Gaginella TS
J Pharmacol Exp Ther; 1990 Nov; 255(2):572-6. PubMed ID: 2173749
[TBL] [Abstract][Full Text] [Related]
17. Effects of thromboxane synthase inhibition on in vivo release of inflammatory mediators in chronic ulcerative colitis.
Casellas F; Papo M; Guarner F; Antolín M; Segura RM; Armengol JR; Malagelada JR
Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):221-6. PubMed ID: 7743303
[TBL] [Abstract][Full Text] [Related]
18. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
19. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease.
Nishida Y; Murase K; Isomoto H; Furusu H; Mizuta Y; Riddell RH; Kohno S
Hepatogastroenterology; 2002; 49(45):678-82. PubMed ID: 12063968
[TBL] [Abstract][Full Text] [Related]
20. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
Griga T; Voigt E; Gretzer B; Brasch F; May B
Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
